Work

Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Year: 2018

Type: article

Study design: Clinical Trial

Source: Leukemia

DOI: 10.1038/s41375-018-0038-8

Authors: Amrita Krishnan, Prashant Kapoor, Joycelynne M. Palmer, Ni-Chun Tsai, Shaji Kumar, Sagar Lonial, Myo Htut, Chatchada Karanes, Nitya Nathwani, Michael Rosenzweig, Firoozeh Sahebi, George Somlo, Lupe Duarte, James F. Sanchez, Daniel Auclair, Stephen J. Forman, Jesus G. Berdeja

Institutions: City Of Hope National Medical Center, City of Hope, Mayo Clinic, Emory University, Winship Cancer Institute, Kaiser Permanente, Multiple Myeloma Research Foundation, Sarah Cannon

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Award: G772794905

OpenAlex ID: W2776494374

FWCI: 4.575

Cites: 47

Cited by: 51

Related to: 10